Comparison of sympathomimetic effectiveness in children with congenital heart diseases after cardiopulmonary bypass surgery
Keywords:
adrenaline, dopamine, sympathomimetics, children, congenital heart disease, cardiopulmonary bypass
Abstract
The current work evaluates the application of sympathomimetic drugs in infants with congenital heart diseases after cardiopulmonary bypass surgery. The comparison between adrenaline and dopamine in the treatment of postoperative myocardial dysfunction, the frequency of postoperative complications and the length of stay in the intensive care unit was accomplished.
References
1. Patwardhan K. Inotropes in term neonates // Infant. – 2011. – Vol. 5 (1). – P. 12–17.
2. Munoz R., Da Cruz E., Vetterly C. G. Handbook of Pediatric Cardiovascular Drugs. 2d Edition. – London : Springer-Verlag, 2014. – P. 16–18.
3. Chaturvedi R. R., Herron T., Simmons R., et al. Passive stiffness of myocardium from congenital heart disease and implications for diastole // Circulation. – 2011. – Vol. 121. – P. 979–988.
4. Bronicki R., Chang A. Management of the postoperative pediatric cardiac surgical patient // Crit. Care Med. – 2011. – Vol. 39 (8). – P. 1974–1980.
5. Ruoss L., McPherson C., DiNardo J. Inotrope and vasopressor support in neonates // Neo Reviews. – 2015. – Vol. 16. – P. e351–e358.
6. Andropoulos D., Stayer S. et al. Anesthesia for congenital heart disease. 2d Edition. West Sussex, UK : Blackwell Publishing Ltd, 2010. – P. 430–502.
7. Stark J., de Leval M., Tsang V. T. Surgery for congenital heart defects. 3d Ed. London : John Wiley & Sons Ltd, 2006. – P. 187–244.
8. Choudhury M., Saxena N. Inotropic agents in pediatric cardiac surgical patients: current practice, concerns and controversies // Indian J. Anesth. – 2006. – Vol. 47 (4). – P. 246–253.
9. Brierley J., Carcillo J. Etal Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock // Crit Care Med. – 2009. – Vol. 37. – P. 667–681.
10. Kern M. J. The Cardiac Catheterization Handbook (6th Edition). – London : Mosby, 2016.
2. Munoz R., Da Cruz E., Vetterly C. G. Handbook of Pediatric Cardiovascular Drugs. 2d Edition. – London : Springer-Verlag, 2014. – P. 16–18.
3. Chaturvedi R. R., Herron T., Simmons R., et al. Passive stiffness of myocardium from congenital heart disease and implications for diastole // Circulation. – 2011. – Vol. 121. – P. 979–988.
4. Bronicki R., Chang A. Management of the postoperative pediatric cardiac surgical patient // Crit. Care Med. – 2011. – Vol. 39 (8). – P. 1974–1980.
5. Ruoss L., McPherson C., DiNardo J. Inotrope and vasopressor support in neonates // Neo Reviews. – 2015. – Vol. 16. – P. e351–e358.
6. Andropoulos D., Stayer S. et al. Anesthesia for congenital heart disease. 2d Edition. West Sussex, UK : Blackwell Publishing Ltd, 2010. – P. 430–502.
7. Stark J., de Leval M., Tsang V. T. Surgery for congenital heart defects. 3d Ed. London : John Wiley & Sons Ltd, 2006. – P. 187–244.
8. Choudhury M., Saxena N. Inotropic agents in pediatric cardiac surgical patients: current practice, concerns and controversies // Indian J. Anesth. – 2006. – Vol. 47 (4). – P. 246–253.
9. Brierley J., Carcillo J. Etal Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock // Crit Care Med. – 2009. – Vol. 37. – P. 667–681.
10. Kern M. J. The Cardiac Catheterization Handbook (6th Edition). – London : Mosby, 2016.
Published
2016-12-02
How to Cite
1.
Khemio Arnes S, Moshkivska L, Teslar M, Cheburahin V, Boyko S, Lazoryshynetz V. Comparison of sympathomimetic effectiveness in children with congenital heart diseases after cardiopulmonary bypass surgery. ujcvs [Internet]. 2016Dec.2 [cited 2024Dec.22];(3 (26):83-6. Available from: http://cvs.org.ua/index.php/ujcvs/article/view/209
Section
CONGENITAL HEART DEFECTS
